role of rebates in glp-1 pbm decisions Drive U.S. Payer Coverage Agonists GLP-1 Costs Explained: Managing Coverage

References National Institutes of Health World Health Organization MedlinePlus National Center for Complementary and Integrative Health This article is for general information only and is not a substitute for professional medical advice

Gastrointestinal distress is a commonly reported side effect of GLP-1s, impacting roughly 40% to 70% of patients

But I'm not sure whether it will affect mobilization of liver stores of B12

For patients, the promise of effective weight loss coupled with health improvements is appealing

The administration of BPC157 was well tolerated by all rats, and no visual signs of toxicity were observed, consistent with our previous safety evaluation studies (Xu et al., 2020)

Thats really one that I dont know if thats true, but its a big concern in the back of my mind every time someone asks me about that